Camp4 Therapeutics Corp

Ownership Transactions Reported by 21 Insiders

Symbol
CAMP on Nasdaq
Industry
Pharmaceutical Preparations
Location
One Kendall Square, Building 1400 West, 3 Rd Floor, Cambridge, MA

Insiders trading volume in the past year

Camp4 Therapeutics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
5AM Partners VI, LLC 10%+ Owner $10.4M +$4.5M +76.1% Sep 11, 2025
Andrew J. Schwab Director, 10%+ Owner $10.4M Sep 11, 2025
Josh Mandel-Brehm Chief Executive Officer, Director $459K +$10K +2.23% Sep 11, 2025
Polaris Management Co. VII, L.L.C. 10%+ Owner $302K +$2M Sep 11, 2025
Amir Nashat Director, 10%+ Owner $302K +$2M Sep 11, 2025
Richard A. Young Director $281K +$25K +9.78% Sep 11, 2025
Kelly Gold Chief Financial Officer $112K +$10K +9.8% Sep 11, 2025
Yuri Maricich Chief Medical Officer $10K +$10K Sep 11, 2025
David Bumcrot Chief Scientific Officer Apr 1, 2025
James P. Boylan Director Jun 25, 2025
Polaris Partners GP X, L.L.C. 10%+ Owner Oct 15, 2024
Murray Stewart Director Mar 17, 2025
Douglas E. Williams Director Mar 17, 2025
Northpond Ventures II GP, LLC 10%+ Owner Oct 15, 2024
Ravi I. Thadhani Director Jun 25, 2025
Paula Ragan Director Jun 25, 2025
Michael J. Higgins Director Jun 25, 2025
Ingo Chakravarty Director Oct 10, 2024
Steven H. Holtzman Director Jun 25, 2025
AH Equity Partners Bio I, L.L.C. 10%+ Owner Oct 15, 2024
Enavate Sciences GP, LLC 10%+ Owner Oct 15, 2024

Recent Insider Transactions by Companies or Individuals for Camp4 Therapeutics Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.